Crime Syndicate Producing Counterfeit E-Cigarettes in Youth-Friendly Shapes

Regulations by 2FIRSTS.ai
May.16.2024
Crime Syndicate Producing Counterfeit E-Cigarettes in Youth-Friendly Shapes
Shandong police dismantle criminal gang producing fake e-cigarettes shaped as drinks, targeting minors, involving over 10 million yuan.

According to a report from Beijing News Network on May 16, after two months of in-depth investigation, the police in Dongying City, Shandong Province successfully dismantled a criminal gang specializing in producing counterfeit e-cigarettes. The gang was making e-cigarettes in the shape of "milk tea cups" and "coke cans" to deceive minors into purchasing them under the guise of quitting smoking. The amount involved in the case was as high as more than 10 million yuan.

 

On January 29, 2024, the Kekou Sub-bureau of the Dongying Public Security Bureau in Shandong Province received a report from the district Tobacco Bureau that a store in its jurisdiction was suspected of selling fruit-flavored e-cigarettes to minors. The police quickly took action and seized 109 disposable non-standard e-cigarettes with names such as "Milk Tea Cup," "Rabbit Cup," "Cola Can," "Little Tiger," and "Ice Bear" as well as 504 pods at the scene of the store. Two suspects, Zhang and Wu, were arrested for suspected illegal e-cigarette sales.

 

During the period from October 2022 to January 2024, the criminal suspect Wu and the upstream and downstream criminal suspects Yuan, Huang, Zhang and others engaged in the illegal operation of e-cigarettes, using online social platforms to arrange the types and quantities of e-cigarettes and make online payments. The group transported goods through logistics, mainly targeting teenagers in 6 provinces in China, with monetary transactions amounting to over 10 million RMB.

 

Following this, the Kenli Sub-bureau established a special task force to crack down on illegal activities. They retrieved over 20,000 pieces of relevant data information through various channels about two suspected criminals, successfully tracing back to a criminal gang led by Gao, Fu, and Yuan that was illegally smuggling Vietnamese, Hong Kong, and Japanese versions of e-cigarettes.

 

Currently, the individuals involved in the case have been arrested, and the case is being processed according to the law.

 

According to Article 18 of the "Regulations on the Management of E-cigarettes", it is prohibited to set up e-cigarette sales outlets near ordinary primary and secondary schools, special education schools, secondary vocational schools, specialized schools, and kindergartens. Article 22 stipulates that it is prohibited to sell e-cigarette products to minors. E-cigarette operators should prominently display signs indicating that they do not sell e-cigarettes to minors; for those who are difficult to determine whether they are minors, they should be required to show identification documents.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

InterTabac 2025 Insights|RELX Unveils “Vaporless” Showcase Cabinet Featuring Nicotine Airpouch and Prototype Vaporless Device
InterTabac 2025 Insights|RELX Unveils “Vaporless” Showcase Cabinet Featuring Nicotine Airpouch and Prototype Vaporless Device
At InterTabac 2025, RELX’s oral-nicotine showcase featured leaf-shaped Nicotine Airpouch products under the WAKA, RELX, and DOSH brands, alongside a prototype “vaporless oral product.” The device produces no visible aerosol upon exhalation during light puffs and is currently for exhibition only, with no confirmed launch timeline. RELX also displayed a nose-inhaled e-cigarette that differs from conventional mouth-inhaled vaping by requiring nasal inhalation.
Sep.20 by 2FIRSTS.ai
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
As the UK prepares to introduce its first-ever vape tax in 2026, questions are growing about how the measure will reshape the country’s harm reduction landscape. IBVTA tells 2Firsts that while it was not in favour of the new duty, it accepts that it is being implemented and is working with regulators to ensure a smooth rollout — warning, however, that higher costs could slow smokers’ transition to safer alternatives.
Oct.07
Hounslow Crackdown Seizes £33,000 of Illegal Vapes and Combustible Cigarettes
Hounslow Crackdown Seizes £33,000 of Illegal Vapes and Combustible Cigarettes
Hounslow Council’s Trading Standards team, working with Metropolitan Police units, conducted test purchases across the borough and found seven premises selling illegal tobacco. Subsequent raids at 16 premises in Chiswick, Feltham and Hounslow High Street seized 4,859 illegal vapes (≈£30,000), 3,806 combustible cigarettes (≈£3,000), 16kg of shisha and 11kg of chewing tobacco. Offences included oversized tanks, over-strength nicotine, and unregistered products.
Oct.22 by 2FIRSTS.ai
Geek Bar Launches New Pulse Models in the U.S.: Thermochromic Design, Core Specs Intact
Geek Bar Launches New Pulse Models in the U.S.: Thermochromic Design, Core Specs Intact
U.S. vape retailer VapeSourcing has listed GEEKBAR Pulse 15K/25K Thermal Edition products, currently marked “Coming Soon.” Both models retain the core Pulse-series configuration but adopt a thermochromic, color-changing shell; the Pulse 15K is flagged as GEEKBAR’s first device to use this finish.
Nov.04 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai